Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2012
08/08/2012CN101307310B Expression system with recombination protein for increasing yield and immunogenicity
08/08/2012CN101092636B Selectively replicating viral vectors, preparation method and application
08/07/2012US8237021 Insecticidal proteins derived from Bacillus thuringiensis
08/07/2012US8237020 Expression and use of novel pesticidal toxins
08/07/2012US8237013 Means and methods for controlling flowering in plants
08/07/2012US8236936 Production of recombinant selenoprotein mutants with enhanced catalytic activity
08/07/2012US8236929 Method and system for production of zein and/or xanthophylls using chromatography
08/07/2012US8236928 Genes differentially expressed in breast cancer
08/07/2012US8236926 Chemoselectively ligating sugar moiety to alkoxylamine-containing vancomycin; for inhibiting growth of resistant Enterococci
08/07/2012US8236924 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236767 Methods for treating inflammation using B7-H4 polypeptides and fragments thereof
08/07/2012US8236764 Methods for treating a hemostasis related disorder using activated forms of Factor V
08/07/2012US8236762 Peptide-cytotoxic conjugates
08/07/2012US8236757 AXMI-027, AXMI-036 and AXMI-038, a family of delta-endotoxin genes and methods for their use
08/07/2012US8236753 RAP variants for drug delivery and methods of use thereof
08/07/2012US8236561 Transgenic cells comprising immunoglobulin nucleotides and expressing adenoviral early genes for use as bioreactors in production of preferential antibodies; immunotherapy
08/07/2012US8236556 Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
08/07/2012US8236526 Calcium-binding photoprotein, gene encoding the same, and use thereof
08/07/2012US8236510 Protein showing enhanced expression in cancer cells
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236494 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
08/07/2012US8236488 Method of screening for therapeutic compounds for vascular disorders and hypertension based on URAT1 activity modulation
08/07/2012US8236344 Engineered proteins, and methods of making and using
08/07/2012US8236326 Klebsiella antigens
08/07/2012US8236325 S. epidermidis antigens
08/07/2012US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
08/07/2012US8236295 Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses
08/07/2012CA2551102C Genes encoding proteins with pesticidal activity
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/07/2012CA2429384C Concatameric immunoadhesion
08/07/2012CA2411927C Immunization of dairy cattle with gapc protein against streptococcus infection
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2390057C High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam)
08/07/2012CA2368088C Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines
08/07/2012CA2328394C Transgenic plants with modified activity of a plastidial adp/atp translocator
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/07/2012CA2309676C Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
08/07/2012CA2286344C Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012103324A2 Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto
08/02/2012WO2012102999A1 Novel bacillus thuringiensis genes with lepidopteran activity
08/02/2012WO2012102331A1 Human il-17-producing helper t cell detection marker and human il-17-producing helper t cell detection method
08/02/2012WO2012101616A1 Antiviral peptides
08/02/2012WO2012101509A2 Immunological compositions against hiv
08/02/2012WO2012101413A1 Novel compounds and their effects on feeding behaviour
08/02/2012WO2012101157A1 Human lactoferrin derived peptides and there use
08/02/2012WO2012101156A2 New synthetic peptides and their use
08/02/2012WO2012101136A1 ENDO Tv, A NOVEL HIGH-MANNOSE-SPECIFIC ENDO-ß-N-ACETYLGLUCOSAMINIDASE FROM TRICHODERMA VIRIDE
08/02/2012WO2012101112A1 Cyaa-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses
08/02/2012WO2012100342A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012075549A3 Agents for increased resistance against oxidative stress conditions
08/02/2012WO2012070962A3 Process and apparatus for freezing in plates to obtain ice matrixes with a uniform distribution of solutes
08/02/2012WO2012058493A3 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
08/02/2012WO2012058363A3 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
08/02/2012WO2012048291A3 Compositions and methods for inhibition of mmp:mmp-substrate interactions
08/02/2012WO2012036884A3 Bioproduction of aromatic chemicals from lignin-derived compounds
08/02/2012WO2012036410A9 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
08/02/2012WO2012028759A3 Anticaries compositions and probiotics/prebiotics
08/02/2012WO2012009648A3 Novel nitrate reductase fusion proteins and uses thereof
08/02/2012WO2011113579A3 Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use
08/02/2012WO2011092473A8 Novel compounds and their effects on feeding behaviour
08/02/2012US20120197006 Modified interferon beta polypeptides and their uses
08/02/2012US20120197005 Containerless synthesis of amorphous and nanophase organic materials
08/02/2012US20120196922 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
08/02/2012US20120196805 Compositions and methods to control angiogenesis with cupredoxins
08/02/2012US20120196804 Glucagon analogs exhibiting physiological solubility and stability
08/02/2012US20120196802 Modified exendins and uses thereof
08/02/2012US20120196798 Glp-1 analogues and their pharmaceutical salts and uses
08/02/2012US20120196372 Methods for Reducing Gluconoylation of Proteins
08/02/2012US20120196361 Mart-1 t cell receptors
08/02/2012US20120196308 Methods and Kits for Measuring Von Willebrand Factor
08/02/2012US20120196306 Compositions and methods for the detection of hiv-1/hiv-2 infection
08/02/2012US20120196295 UV Excitable Fluorescent Energy Transfer Dyes
08/02/2012US20120195989 Carboxymethylarginine Production Inhibitor and Collagen Denaturation Inhibitor
08/02/2012US20120195959 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin
08/02/2012US20120195953 Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
08/02/2012US20120195952 Implantable matrix having optimum ligand concentrations
08/02/2012US20120195927 Gm-negative ehv-mutants without heterologous elements
08/02/2012US20120195926 Methods of improving vaccine immunogenicity
08/02/2012US20120195924 Adenoviral vector vaccine
08/02/2012US20120195920 Staphylococcus aureus div1b for use as vaccine
08/02/2012US20120195919 Hybrid and tandem expression of neisserial proteins
08/02/2012US20120195899 Immunizing Compositions and Methods of Use
08/02/2012US20120195898 Immunizing Compositions and Methods of Use
08/02/2012US20120195883 Monocot seed product comprising a human blood protein
08/02/2012US20120195882 lipoparticle comprising a protein and methods of making and using the same
08/02/2012US20120195866 PKD Ligands and Polynucleotides Encoding PKD Ligands
08/02/2012US20120195861 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
08/02/2012US20120195859 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012US20120195828 Kidney-imaging agent comprising recombinant gelatin
08/02/2012DE19919121B4 Multimeres CMV-Antigen The multimeric CMV antigen
08/02/2012DE102011003478A1 Antivirales Mittel enthaltend rekombinante Mistellektine An antiviral agent containing recombinant mistletoe lectins
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 2916